Performance analysis of Harvard Bioscience (HBIO)
Annual Return
Over the past 3 years, HBIO has had an average annual return of -51.63%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, HBIO has had an average annual return of -38.11%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, HBIO has had an average annual return of -15.85%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Mar 19, 2001, HBIO has had an average annual return of -8.07%, underperforming the benchmark SPY, which returned +9.60% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.84% | -68.30% | -60.57% | +93.15% | -60.71% | +64.33% | +40.66% | -4.09% | -3.63% | +8.20% | -12.10% | -38.81% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| +20.64% | +38.47% | +13.17% | -5.15% | +14.29% | +34.71% | -42.14% | -10.72% | +15.29% | -3.89% | -47.98% | +169.88% |
| 2002 | 2001 | ||||||||||
| -66.82% | +42% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -25.14% | +22.54% | -20.60% | +30.96% | -7.82% | +10.52% | -2.84% | ||||||
| 2025 | -18.95% | -50.67% | -32.93% | -37.01% | +31.05% | -4.99% | +4.89% | +6.29% | -11.40% | +17.82% | +47.37% | -12.12% | -68.30% |
| 2024 | -17.76% | -1.59% | -2.08% | -9.92% | -17.01% | -10.10% | +12.30% | -10.00% | -6.59% | -12.64% | -6.39% | -4.09% | -60.57% |
| 2023 | +7.58% | -5.02% | +48.40% | +36.19% | -2.28% | -1.79% | -15.31% | -5.16% | -2.50% | +2.09% | -2.97% | +25.60% | +93.15% |
| 2022 | -17.45% | -7.21% | +15% | -15.94% | -29.88% | -1.65% | +4.45% | -12.23% | -22.42% | +5.09% | -4.84% | +8.20% | -60.71% |
| 2021 | +8.16% | -5.39% | +24.37% | +26.93% | +1.01% | +19% | -5.28% | +4.69% | -15.50% | +7.88% | -11.15% | +5.38% | +64.33% |
| 2020 | -2.61% | +9.08% | -31.78% | +24.42% | -4.00% | +17.43% | +0.33% | +7.71% | -10.15% | +12.29% | +15.99% | +9.44% | +40.66% |
| 2019 | +7.86% | +17.19% | +7.22% | -10.21% | -41.35% | -11.88% | +23.98% | -0% | +24.20% | -9.09% | +3.58% | +5.16% | -4.09% |
| 2018 | +42.43% | -0% | +6.38% | +14.99% | -23.47% | +21.59% | +6.54% | +4.39% | -11.77% | -24.56% | -0.26% | -19.49% | -3.63% |
| 2017 | -1.64% | -6.67% | -7.13% | -7.70% | -4.16% | +10.85% | +9.81% | +10.71% | +20.97% | -10.66% | -1.49% | +0% | +8.20% |
Drawdown analysis of Harvard Bioscience (HBIO)
The maximum drawdown for the HBIO was -97.42%, occurring on May 28, 2025. This drawdown has not yet recovered.
The current HBIO drawdown is -94.09%.
Since Mar 19, 2001 HBIO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.42% | Aug 31, 2001 | 5968 | May 28, 2025 | Ongoing | Ongoing | Ongoing |
| -27.92% | May 21, 2001 | 8 | Jun 1, 2001 | 55 | Aug 20, 2001 | 63 |
| -17.19% | Mar 21, 2001 | 13 | Apr 9, 2001 | 7 | Apr 19, 2001 | 20 |
| -6.74% | Apr 20, 2001 | 3 | Apr 25, 2001 | 1 | Apr 26, 2001 | 4 |
| -5.21% | May 11, 2001 | 1 | May 14, 2001 | 4 | May 18, 2001 | 5 |
| -2.74% | Aug 20, 2001 | 1 | Aug 21, 2001 | 2 | Aug 23, 2001 | 3 |
| -2.50% | May 1, 2001 | 1 | May 2, 2001 | 2 | May 4, 2001 | 3 |
| -2.08% | Aug 27, 2001 | 1 | Aug 28, 2001 | 3 | Aug 31, 2001 | 4 |
| -1.28% | Apr 26, 2001 | 1 | Apr 27, 2001 | 2 | May 1, 2001 | 3 |
| -1.23% | May 4, 2001 | 2 | May 8, 2001 | 3 | May 11, 2001 | 5 |